Vascularized bone transfer.
We evaluated the results of reconstruction of a skeletal defect with use of a vascularized bone graft from the iliac crest or fibula in 160 patients who had been managed consecutively between 1979 and 1989. The indications for the procedure were a skeletal defect including non-union, resulting from resection of a tumor; traumatic bone loss; osteomyelitis; or a congenital anomaly. The average duration of follow-up was forty-two months (range, twelve to 112 months). For the entire series, the rate of union after the primary procedure was 61 per cent and the over-all rate at the latest follow-up examination (including the patients who had a secondary procedure) was 81 per cent. In a subgroup of seventy-six patients who had union after the primary procedure and did not have additional treatment, the average interval until union was six months and the average interval until full activity was sixteen months. The results were more favorable for the patients who had had reconstruction for resection of a tumor (of sixty-nine patients, fifty-six had union), for a congenital anomaly (of six patients, five had union), or for a non-union without infection (of twenty-five patients, twenty-three had union). The results were less satisfactory for patients who had had the reconstruction for bone loss due to osteomyelitis (of sixty patients, forty-six had union). Our data suggest that vascularized bone transfer for the reconstruction of large skeletal defects is a valuable procedure in appropriately selected patients.
Han
C S
CS
Department of Orthopedics, Mayo Clinic, Rochester, Minnesota 55905.
Wood
M B
MB
Bishop
A T
AT
Cooney
W P
WP
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001847:Bone Diseases / Q000000981:diagnostic imaging / Q000601:surgery*; D001859:Bone Neoplasms / Q000601:surgery; D016025:Bone Transplantation / Q000379:methods*; D001842:Bone and Bones / Q000002:abnormalities; D002648:Child; D002675:Child, Preschool; D005260:Female; D005360:Fibula / Q000098:blood supply* / Q000637:transplantation; D005500:Follow-Up Studies; D006801:Humans; D007085:Ilium / Q000098:blood supply* / Q000637:transplantation; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate
D013669:Technetium Tc 99m Medronate